Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001933414-26-000038 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 21, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
89,700
Total Value
$0.00
P&L
+inf% (+$2,159,079.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 19, 2026 | Grant/Award | 38,400 | $0.00 | $0.00 | 82,489 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Feb 19, 2026 | Grant/Award | 51,300 | $0.00 | $0.00 | 51,300 | Direct | โ | View Details |